PYROGEN TESTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Pyrogen testing is detection of pyrogen in pharmaceutical drugs and devices. The contaminated devices or drugs when introduced in body can cause fever, shock, inflammation, and other problems. Pyrogen testing consists of kits, reagents, and instruments, which enable pyrogen and endotoxins detection by in-vitro methods and minimizes the usage of animal testing.

In June 2012, the U.S. Food and Drug Administration (FDA) provided guidelines for pyrogen and endotoxin testing to industries. Hence, stringent government regulations and rising focus on in-vitro testing for detection of pyrogen are major factors boosting growth of the market.

Market Dynamics

Market players are focusing on development of drugs for the treatment of various diseases such as cancer, which requires pyrogen testing in order to manufacture the drugs. Hence, increasing drug development is expected to boost growth of the global pyrogen testing market. For instance, in April 2019, PharmaCyte Biotech, Inc., a biotechnology company focused on development of cellular therapies for diabetes and cancer, announced that it cleared the pyrogenicity testing of the encapsulation material to manufacture Cell-in-a-Box capsules (CypCaps).

Moreover, according to the Pharma R&D Annual Review, 2019, an estimated number of drugs under pipeline in 2019 was around 16,181, while in 2018, it was around 15,267, resulting in an overall pipeline growth by 6% in 2018.       

Key features of the study

• This report provides in-depth analysis of the global pyrogen testing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pyrogen testing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc., Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc., bioMérieux, Wako Chemicals USA, Inc., Sanquin, Ellab A/S, and Pyrostar
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pyrogen testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pyrogen testing market.

Market Segmentation

• Global Pyrogen Testing Market, By Test Type
  • Limulus Amoebocyte Lysate (LAL) Test
  • TAL Test  
  • Monocyte Activation Test (MAT)
  • Rabbit Pyrogen Test (RPT)
  • Recombinant Factor C Assay (rFC)
• Global Pyrogen Testing Market, By Product Type
  • Instruments
  • Kits 
  • Reagents
• Global Pyrogen Testing Market, By End User
  • Pharmaceutical and Biotech Companies
  • Food and Beverages Companies
  • Others  
• Global Pyrogen Testing Market, By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
  • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Thermo Fisher Scientific,
  • Merck KGaA,
  • Lonza Group,
  • Associates of Cape Cod Inc,
  • Charles River Laboratories Inc,
  • GenScript,
  • WuXi PharmaTech (Cayman), Inc,
  • bioMerieux,
  • Wako Chemicals USA, Inc,
  • Sanquin, Ellab A/S,
  • Pyrostar